HLI

$140.56+1.04 (+0.75%)

Market OpenAs of Mar 17, 5:02 PM UTC

Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructurings and liability management, and financial and valuation advisory services worldwide.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JPMBACGS

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$140.56
Potential Upside
2.5%
Whystock Fair Value$144.06
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorFinancial Services
IndustryCapital Markets

Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructurings and liability management, and financial and valuation advisory services worldwide. The company operates in three segm...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.81B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.56
Beta
Defensive asset. Lower volatility than the S&P 500.
0.96
Div Yield
Strong income play. Yield provides a meaningful total return floor.
172.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
20.47%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.49

Recent News

Simply Wall St.
Mar 14, 2026

How The Evolving Investment Narrative Is Reframing Helia Group’s (ASX:HLI) Fair Value Story

Helia Group’s consensus analyst fair value has shifted slightly, with the target moving from A$4.35 to about A$4.27 per share. This trim lines up with broader research across financial services, where analysts are adjusting targets but not treating Helia as an outlier. As you read on, you will see how this evolving narrative might shape the way you track Helia’s story from here. Stay updated as the Fair Value for Helia Group shifts by adding it to your watchlist or portfolio. Alternatively,...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 13, 2026

Affirm, Houlihan Lokey, Shift4, Fiserv, and Paymentus Stocks Trade Down, What You Need To Know

A number of stocks fell in the afternoon session after investors raised concerns over the stability of the private credit market, following a key announcement from a major bank.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Medical Device Network
Mar 11, 2026

Medtech industry value to be driven by infrastructure over next decade

Analysis by Houlihan Lokey suggests that healthcare institutions are favouring medical equipment that readily fits in with their existing systems.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 6, 2026

Houlihan Lokey, State Street, Stifel, Blackstone, and TPG Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after the release of a surprisingly weak February jobs report showed an unexpected drop in employment.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 6, 2026

A Look At Houlihan Lokey (HLI) Valuation After Recent Share Price Weakness

What Houlihan Lokey's Recent Share Performance Signals for Investors Houlihan Lokey (HLI) has drawn fresh attention after a period of weaker share performance, with the stock showing a 2.6% decline over the past day and a 12.5% decline over the past 3 months. See our latest analysis for Houlihan Lokey. At a share price of US$157.30, Houlihan Lokey’s recent 1 day and 7 day share price declines sit against a modest 1 year total shareholder return of 1.35% and a much stronger 83.26% total...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.